Semaglutide, a type of GLP-1RA, was found by Sadek et al (163) to inhibit GSK-3 activity through the PI3K/Akt/GSK-3 pathway, promoting glycogen synthesis in muscle
Think of your 503A compounding pharmacy as your local individualized compounding pharmacy
In the worst scenario, you end up with medications that are potentially harmful. Some people who cant find semaglutide at their regular pharmacy have turned to compounding pharmacies, which mix or alter drug ingredients to create medications tailored to specific patient needs
Liver fat reduction: a bonus benefit An important secondary finding from the clinical trials: after 48 weeks of treatment with the two highest doses of retatrutide, 90% of participants with elevated liver fat at baseline achieved normalization
For the purpose of preserving muscle during a deficit, what matters is that the last two or three repetitions of each set are genuinely hard and that the load can be progressed over time